Copyright © 2004 American Chemical Society
 

August 9, 2004 Issue

Volume 82, Issue 32
8232cov1_Ichikawa
August 9, 2004 Issue, Vol. 82 | Iss. 32
Novel chemical and enzymatic oligosaccharide synthesis techniques could lead to a new generation of carbohydrate-based vaccine agents
By STU BORMAN, C&EN WASHINGTON
(pp. 31-35)
Features
Science & Technology
Oxygen vacancies are nanoengineered and imaged with atomic precision 
Science & Technology
Athens lab is set to work nonstop to help ensure a level playing field at the Summer Olympics (pp. 26-29)
Back Issues
 

News of the Week

Hubble Shows Its Age

Telescope experiences failure of one of its four scientific instruments
(p.1)

DOPING AT THE NANOSCALE

Oxygen vacancies are nanoengineered and imaged with atomic precision
(p.6)

LILLY TO POST CLINICAL DATA

Website registry follows a push for public disclosure on drug risks
(p.7)

TWO COMPANIES GET NEW CEOS

Dow elevates Liveris to top spot, and Cambrex hires Leone from Aventis
(p.7)

VENOM YIELDS TREASURE TROVE

NMR spectroscopy reveals unexpected sulfated nucleosides in spider venom
(p.8)

ANTIBODIES FIGHT ALZHEIMER'S

Immune therapy clears both plaques and tangles in the brains of mice
(p.9)

REGISTRATION STREAMLINED

EPA will no longer consult with wildlife agencies on pesticides
(p.9)

BUSH ACTS ON 9/11 PANEL SUGGESTIONS

President endorses intelligence czar, new counterterrorism center
(p.10)
 

Departments

notw1images

Science & Technology

Athens lab is set to work nonstop to help ensure a level playing field at the Summer Olympics
(pp. 26-29)
Messenger RNA-cleaving protein, active in RNA interference, is identified as Argonaute 2
(p.30)
Novel chemical and enzymatic oligosaccharide synthesis techniques could lead to a new generation of carbohydrate-based vaccine agents
(pp. 31-35)

Editor's Page

Letters

Letters(pp. 4-5)